Summary:
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping function of the left side of the heart
Qualified Participants Must:
• At least 18 years and at the legal age of consent
•
Chronic HF diagnosed at least 3 months before Visit 1
•
other requirements need to be met to join the trial
Qualified Participants May Receive:
Compensation
Available if qualified